Key Takeaways ACB's medical cannabis revenues rose nearly 25% to C$135.3M, making up 72% of net revenues.Aurora Cannabis saw higher international sales lift margins and helped adjusted EBITDA jump 92% to C$26.2M.ACB is scaling back low-margin consumer cannabis as competition and price pressure weigh on that segment.Aurora Cannabis (ACB) sits at the intersection of a shifting regulatory landscape as the Trump administration moves to reclassify marijuana. While the decision marks a constructive step for the c ...